Diabetes drug copycat put to the test in healthy volunteers
NCT ID NCT07633028
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checked if a generic version of a diabetes combination pill (empagliflozin/metformin) works the same as the brand-name version in the body. 42 healthy adults took a single dose of each pill under fed conditions. The goal was to see if the two pills are bioequivalent, meaning they produce similar drug levels in the blood. This type of study helps ensure generic medicines are safe and effective alternatives.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Axis Clinicals Latina, S.A. de C.V.
Mexico City, Mexico City, 07870, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Will a new drug form work the same? study tests two versions of SKI-O-703
- Generic diabetes combo pill put to the test in healthy volunteers
- Diabetes drug showdown: are two pills equally effective?
- Generic diabetes combo drug put to the test in healthy volunteers
- Generic Alzheimer's patch put to the test in healthy volunteers
- New combo pill for heart failure put to the test in healthy volunteers